5-Oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid

Catalog No. :
ACXPBC098
CAS No. :
1224944-46-0
Molecular Formula :
C7H5N3O3
Molecular Weight :
179.13

IUPAC Name:5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid

5-Oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$164.00Login to see priceIn stockIn stock
25g98%$795.00Login to see priceInquiryIn stock
100g98%$2595.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid
IUPAC Name5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid
MDL No.MFCD20660725
Molecular FormulaC7H5N3O3
Molecular Weight179.13
SMILESO=C(C1=C2NC(C=CN2N=C1)=O)O
InChI KeyBUPOQCSUQCCPAW-UHFFFAOYSA-N
SynonymSY242017 | 5-Oxo-4,5-dihydro-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | 5-Oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid | BCP24643 | 5-Oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid, AldrichCPR | AS-32300 | 5-oxo-4,5-dihydropyr
CAS No.1224944-46-0
PubChem CID135741773

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXPBC098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRNTL613 route compound structure diagram
    ACRNTL6131224944-45-9 In Stock
  2. Then
  3. ACXPBC098 route product structure diagram
    ACXPBC0981224944-46-0 In Stock
Inquiry

2. ACXPBC098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPMIQ865 route compound structure diagram
    ACPMIQ8651026456-01-8 In Stock
  2. Then
  3. ACXPBC098 route product structure diagram
    ACXPBC0981224944-46-0 In Stock
Inquiry

Comments (0)